These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22860749)

  • 21. Screening drugs for myocardial disease in vivo with zebrafish: an expert update.
    Zhao Y; Zhang K; Sips P; MacRae CA
    Expert Opin Drug Discov; 2019 Apr; 14(4):343-353. PubMed ID: 30836799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioning.
    Datti A
    Drug Discov Today; 2023 May; 28(5):103522. PubMed ID: 36764576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in capillary electrophoresis and the implications for drug discovery.
    Ouimet CM; D'amico CI; Kennedy RT
    Expert Opin Drug Discov; 2017 Feb; 12(2):213-224. PubMed ID: 27911223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-impedance-based label-free technology for the identification of new drugs.
    Lundstrom K
    Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel targets with high throughput RNA interference screening.
    Kassner PD
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):175-84. PubMed ID: 18336211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.
    Cho CH; Nuttall ME
    Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?
    Jhoti H; Rees S; Solari R
    Expert Opin Drug Discov; 2013 Dec; 8(12):1449-53. PubMed ID: 24206191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fulfilling the promise: drug discovery in the post-genomic era.
    Chanda SK; Caldwell JS
    Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The re-emergence of natural products for drug discovery in the genomics era.
    Harvey AL; Edrada-Ebel R; Quinn RJ
    Nat Rev Drug Discov; 2015 Feb; 14(2):111-29. PubMed ID: 25614221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streamlining drug discovery assays for cardiovascular disease using zebrafish.
    Pott A; Rottbauer W; Just S
    Expert Opin Drug Discov; 2020 Jan; 15(1):27-37. PubMed ID: 31570020
    [No Abstract]   [Full Text] [Related]  

  • 32. High throughput screening for autophagy.
    Forveille S; Leduc M; Sauvat A; Cerrato G; Kroemer G; Kepp O
    Methods Cell Biol; 2021; 165():89-101. PubMed ID: 34311873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections.
    Cowell AN; Winzeler EA
    Genome Med; 2019 Oct; 11(1):63. PubMed ID: 31640748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From high content screening to target deconvolution: New insights for phenotypic approaches].
    Shabajee P; Gaudeau A; Legros C; Dorval T; Stéphan JP
    Med Sci (Paris); 2021 Mar; 37(3):249-257. PubMed ID: 33739272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional cell-based uHTS in chemical genomic drug discovery.
    Croston GE
    Trends Biotechnol; 2002 Mar; 20(3):110-5. PubMed ID: 11841862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beautiful cell: high-content screening in drug discovery.
    Bickle M
    Anal Bioanal Chem; 2010 Sep; 398(1):219-26. PubMed ID: 20577725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing, optimizing, and implementing high-throughput siRNA genomic screening with glioma cells for the discovery of survival genes and novel drug targets.
    Thaker NG; McDonald PR; Zhang F; Kitchens CA; Shun TY; Pollack IF; Lazo JS
    J Neurosci Methods; 2010 Jan; 185(2):204-12. PubMed ID: 19782703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automated Microscopy and High Content Screens (Phenotypic Screens) in Academia Labs.
    Moreau D; Gruenberg J
    Chimia (Aarau); 2016 Dec; 70(12):878-882. PubMed ID: 28661361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-content screening of functional genomic libraries.
    Rines DR; Tu B; Miraglia L; Welch GL; Zhang J; Hull MV; Orth AP; Chanda SK
    Methods Enzymol; 2006; 414():530-65. PubMed ID: 17110210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated microscopy for high-content RNAi screening.
    Conrad C; Gerlich DW
    J Cell Biol; 2010 Feb; 188(4):453-61. PubMed ID: 20176920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.